by [150+ Pages Report] The medical affairs outsourcing market size is projected to reach over US$ 3.51 billion by the end of the year 2030 from US$ 1.45 billion in 2020 at a steady CAGR of 12.5% from 2021 to 2030, according to Precedence Research.
The medical affairs outsourcing market report covers a detailed analysis for the historic period 2017-2020, considering 2021 as the base year and forecast (growth) for 2021-2030.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1113
Growth Factors
Global medical affairs outsourcing market is propelled by escalating research and developments undertakings along with growing spending in the healthcare sector across the globe. Further rising emphasis on CROs and CMOs is supporting the market growth across different economies in the world. Geographically, Asia Pacific is expected projected show significant growth in the global market on account of fast turnaround period and stress-free obtainability of the trained and skilled professionals at low cost. Furthermore, augmented clinical trials across the world are also triggering the growth of global medical affairs outsourcing market. As per statistics offered by Word Health organization, the yearly number of registered clinical trials augmented from 3,344 in year 2004 to around 54,894 in the year 2018. As medical affair is significant support action for a successful clinical trial, its cumulative number is predicted to flourish growth of medical affairs outsourcing market during the years to come.
Market Report Scope
| Report Highlights | Details |
| Market Size | US$ 3.51 billion by 2030 |
| Growth Rate | CAGR of 12.5% From 2021 and 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | By Services, By Industry and Regional |
| Regional Scope | North America, APAC, Europe, Latin America, MEAN, Rest of the World |
For More Information or Customization Before Buying, Visit @ https://www.precedenceresearch.com/customization/1113
This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global medical affairs outsourcing market for the forecast period of 2021–2030. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.
The report analyzes the historical and present-day scenario of the global medical affairs outsourcing market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.
Key Highlights
- In 2019, medical writing & publishing appeared as most promising segment and garnered maximum revenue share of the total market
- Cumulative R&D activities and expansion of novel products to lift the growth of medical regulatory affairs outsourcing market across the world
- Pharmaceutical industry segment conquered the global market by accounting prominent share more than 50% of the total revenue generated by market in 2019.
- The Medical Science Liaisons (MSLs) services segment projected to record firmest CAGR during assessment period.
- North America occupied for the prominent revenue chunk of the total gathered by global medical affairs outsourcing market in 2019 across various segments.
- Asia Pacific is projected to record the utmost compounded annual growth throughout the estimate period due to contributing factors such as accessibility of low-cost labor and intensifying cases of regulatory filings.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1113
Competition Landscape
In the final section of the research report, Precedence Research provided the global medical affairs outsourcing market structure and a detailed competition landscape to provide a dashboard view of key players operating in the global market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.
Some of the major players in the medical affairs outsourcing market include:
- ICON plc
- Wuxi Clinical Development, Inc
- Pharmaceutical Product Development, LLC
- Ashfield Healthcare Communications
- Indegene Inc.
- IQVIA Holdings Inc
- The Medical Affairs Company (TMAC)
- SGS SA
- Syneos Health Inc
- ZEINCRO Group
Market Segmentation
By Services
- Medical Monitoring
- Medical Writing & Publishing
- Medical Information
- Medical Science Liaisons
- Others
By Industry
- Medical Devices
- Pharmaceutical
- Biopharmaceutical
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
- Market estimate for 2020
- Average selling price (ASP) per region for specific product type
- Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
- Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
- National government documents, statistical databases
- News articles, press releases, and webcasts specific to companies operating in the market
- Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
- Determination of market penetration by country
Most Asked Questions –
What was the market size value of the medical affairs outsourcing in 2020?
What is the expected market size by 2030?
What is the medical affairs outsourcing market growth?
What are the key factors that positively influence market growth?
Who are the prominent players in the medical affairs outsourcing market?
Why Buy this Report?
The purpose of Precedence Research’s medical affairs outsourcing market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Affairs Outsourcing Market, By Services
7.1. Medical Affairs Outsourcing Market, by Services Type, 2021-2030
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Medical Affairs Outsourcing Market, By Industry
8.1. Medical Affairs Outsourcing Market, by Industry, 2021-2030
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Industry (2017-2030)
Chapter 10. Company Profiles
10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1113
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: mailto:sales@precedenceresearch.com
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
